Team Health Holdings CEO Unloads $1,338,120 in Stock (TMH)
Team Health Holdings (NYSE:TMH) CEO Greg Roth unloaded 23,600 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $56.70, for a total transaction of $1,338,120.00. Following the completion of the sale, the chief executive officer now directly owns 146,664 shares of the company’s stock, valued at approximately $8,315,849. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Team Health Holdings (NYSE:TMH) traded up 0.64% during mid-day trading on Monday, hitting $56.54. 426,879 shares of the company’s stock traded hands. Team Health Holdings has a 52-week low of $36.41 and a 52-week high of $57.80. The stock’s 50-day moving average is $53.0 and its 200-day moving average is $48.30. The company has a market cap of $3.994 billion and a P/E ratio of 38.22.
Team Health Holdings (NYSE:TMH) last released its earnings data on Tuesday, July 29th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.08. The company had revenue of $675.10 million for the quarter, compared to the consensus estimate of $650.16 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 16.5% on a year-over-year basis. Analysts expect that Team Health Holdings will post $2.30 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Stifel Nicolaus upgraded shares of Team Health Holdings from a “hold” rating to a “buy” rating in a research note on Thursday, August 7th. They now have a $63.00 price target on the stock, up previously from $57.00. Separately, analysts at Deutsche Bank upgraded shares of Team Health Holdings from a “hold” rating to a “buy” rating in a research note on Thursday, August 7th. They now have a $57.00 price target on the stock, down previously from $63.00. Finally, analysts at Zacks upgraded shares of Team Health Holdings from a “neutral” rating to an “outperform” rating in a research note on Monday, August 4th. They now have a $58.00 price target on the stock. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $61.00.
Team Health Holdings, Inc is a supplier of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States, based upon revenues, patient visits, and number of clients.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.